Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2005
09/21/2005EP1576964A1 Protease inhibitor
09/21/2005EP1576963A2 Method for treating pain by peripheral administration of a neurotoxin
09/21/2005EP1576952A1 Hydrogel microspheres with improved release profile
09/21/2005EP1576951A1 Formulations for the rectal administration of thrombolytically-active agents
09/21/2005EP1576372A1 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a4 (pde9a4)
09/21/2005EP1576368A2 Methods of detecting the inhibition of fibrocyte formation and methods and compositions for enhancing fibrocyte formation
09/21/2005EP1576179A2 Methods and compositions for inducing apoptosis in cancer cells
09/21/2005EP1576170A2 Nucleic acids and corresponding proteins entitled 191p4d12(b) useful in treatment and detection of cancer
09/21/2005EP1576169A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1576168A2 Therapeutic polypeptides nucleic acids encoding same and methods of use
09/21/2005EP1576162A1 Chimeric protein for the screening of agonists and antagonists of cell signalling pathways that are dependent on g-protein-coupled receptors
09/21/2005EP1576155A1 Oligoribonucleotides for treating degenerative skin disorders by rna interference
09/21/2005EP1576153A2 Device and process for the preparation of autologous thrombin serum
09/21/2005EP1576151A2 Ap1 amine oxidase variants
09/21/2005EP1576142A2 Identification of oligoadenylate synthetase-like genes
09/21/2005EP1576141A2 Polynucleotide encoding novel human g-protein coupled receptors, and splice variants thereof
09/21/2005EP1576138A2 2-branched nucleosides and flaviviridae mutation
09/21/2005EP1576137A2 Compositions and methods for the treatment of immune related diseases
09/21/2005EP1576135A2 Method for regulating dopamine producing cells
09/21/2005EP1576132A2 Nucleic acids and corresponding proteins entitled 273p4b7 useful in treatment and detection of cancer
09/21/2005EP1576130A2 Nucleic acids and corresponding proteins entitled 282p1g3 useful in treatment and detection of cancer
09/21/2005EP1576128A2 Products and processes for modulating peptide-peptide binding domain interactions
09/21/2005EP1576124A2 Heat shock protein binding fragments of cd91, and uses thereof
09/21/2005EP1576122A2 Isolated mammalian membrane protein genes; related reagents
09/21/2005EP1576120A2 Antimicrobial compounds from bacillus subtilis for use against animal and human pathogens
09/21/2005EP1576118A2 ALLELE-SPECIFIC siRNA-MEDIATED GENE SILENCING
09/21/2005EP1576113A2 Tumor antigens bfa4 and bcy1 for prevention and/or treatment of cancer
09/21/2005EP1576112A2 Cytokine receptor zcytor17 multimers
09/21/2005EP1576110A2 Cell migration inhibiting compositions and methods and compositions for treating cancer
09/21/2005EP1576108A2 Nitrilases, nucleic acids encoding them and methods for making and using them
09/21/2005EP1576105A2 Stabilized anti-respiratory syncytial virus (rsv) antibody formulations
09/21/2005EP1576104A2 Nucleic acids and corresponding proteins entitled 202p5a5 useful in treatment and detection of cancer
09/21/2005EP1576102A2 Amidases, nucleic acids encoding them and methods for making and using them
09/21/2005EP1576088A2 Dominant negative proteins and methods thereof
09/21/2005EP1576086A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1576010A2 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix
09/21/2005EP1576006A2 Novel preadipocyte factor-1-like polypeptides
09/21/2005EP1576004A2 An immunomodulatory protein derived from trypanosomes and uses thereof
09/21/2005EP1576003A1 Peptides for preventing, diagnosing and treating animal and/or human leptospirosis
09/21/2005EP1576001A2 Endothelial cell specifically binding peptides
09/21/2005EP1575998A2 Mammalian cell culture processes for protein production
09/21/2005EP1575995A2 Activation of peptide prodrugs by hk2
09/21/2005EP1575994A2 Mage-c2 antigenic peptides and uses thereof
09/21/2005EP1575992A2 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
09/21/2005EP1575991A2 Peptides comprising aromatic d-amino acids and methods of use
09/21/2005EP1575989A2 PrP sp sc /sp -INTERACTING MOLECULES AND USES THEREOF
09/21/2005EP1575987A2 Conjugates of membrane translocating agents and pharmaceutically active agents
09/21/2005EP1575984A2 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
09/21/2005EP1575981A1 Angiogenic compounds and uses thereof
09/21/2005EP1575916A2 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
09/21/2005EP1575867A2 Peptide nanostructures and methods of generating and using the same
09/21/2005EP1575672A2 Use of cd137 antagonists for the treatment of tumors
09/21/2005EP1575658A2 Screening and therapeutic methods for treating circadian rhythm disorders
09/21/2005EP1575656A1 Insulin delivery system with sensor
09/21/2005EP1575617A1 Use of topical pharmaceutical compositions comprising an active agent and permeation-enhancing base for the manufacture of a medicament to treat various forms of inflammatory dermatosis
09/21/2005EP1575615A1 Pharmaceutical compositions having an effect on the proliferation of nk cells and a method using the same
09/21/2005EP1575614A1 Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom
09/21/2005EP1575609A2 Methods for treating viral infection using il-28 and il-29
09/21/2005EP1575608A2 Use of cc-chemokine mutants against liver diseases
09/21/2005EP1575607A1 Vanilloid receptor-2 ligands for treating anxiety or depression
09/21/2005EP1575606A1 Treatment of osteoarthritis
09/21/2005EP1575605A1 Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser
09/21/2005EP1575602A2 Methods for treating cancer using porimin as a target
09/21/2005EP1575595A1 Use of a combination containing a non-nucleoside reverse transcriptase inhibitor (nnrti) with an inhibitor of cytochrome p450, such as protease inhibitors
09/21/2005EP1575576A2 Organic compounds
09/21/2005EP1575548A2 Compositions and methods for promoting neuronal outgrowth
09/21/2005EP1575534A2 D4,5 glycuronidase and uses thereof
09/21/2005EP1575531A2 THERAPIES FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY USING INTERFERON-&bgr;
09/21/2005EP1575529A2 Peptides and methods of screening immunogenic peptide vaccines against alzheimer's disease
09/21/2005EP1575528A2 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
09/21/2005EP1575526A2 Dna vaccines encoding heat shock proteins
09/21/2005EP1575525A2 Cell surface tropomyosin as a target of angiogenesis inhibition
09/21/2005EP1575524A2 Proliferated cell lines and uses thereof
09/21/2005EP1575519A2 Cd26-based therapies for cancers and immune disease
09/21/2005EP1575515A2 Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor
09/21/2005EP1575512A2 Methods and compositions for prostate epithelial cell differentiation
09/21/2005EP1575511A2 A new target for angiogenesis and anti-angiogenesis therapy
09/21/2005EP1575504A2 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides
09/21/2005EP1575499A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
09/21/2005EP1575497A2 Novel composition and methods for the treatment of psoriasis
09/21/2005EP1575496A2 Colon tumor specific binding peptides
09/21/2005EP1575490A2 Modified glucagon-like peptide-1 analogs
09/21/2005EP1575485A2 Methods for lightening skin and hair
09/21/2005EP1575482A2 Compositions and method of treating alzheimer's disease
09/21/2005EP1575481A2 Methods to increase or decrease bone density
09/21/2005EP1575480A2 Compositions and methods for the treatment of immune related diseases
09/21/2005EP1575479A2 Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
09/21/2005EP1575477A2 HIGH AFFINITY LIGAND FOR p75 NEUROTROPHIN RECEPTOR
09/21/2005EP1575419A2 Forming iron nitrosyl hemoglobin
09/21/2005EP1575416A2 Methods of diagnosing and treating pre-eclampsia or eclampsia
09/21/2005EP1575379A1 Nutritional compositions
09/21/2005EP1575375A1 Ace inhibitory peptides from plant materials
09/21/2005EP1575354A1 Melusin, a muscle specific protein, as a drug target for prevention and treatment of heart failure
09/21/2005EP1542728A4 Hybrid of itraconazole, cyclosporine or carvedilol with a layered silicate and a process for preparing the same
09/21/2005EP1472280A4 Methods and compositions for oxygen transport comprising an oxygen carrier and a crystalloid in hypertonic solution
09/21/2005EP1435965A4 Pharmaceutical compositions and methods for treating cancer
09/21/2005EP1406694A4 Electro-medical device for use with biologics
09/21/2005EP1404377B1 Improved chelator conjugates
09/21/2005EP1294877B1 Cgi-69 compositions and methods of use
09/21/2005EP1263446B1 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
1 ... 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 ... 3163